特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959783

抗喘息薬・COPD治療薬の世界市場レポート (2020-2030年):COVID 19による影響と成長

Anti-Asthmatics And COPD Drugs Global Market Report 2020-30: Covid 19 Implications and Growth

出版日: | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
抗喘息薬・COPD治療薬の世界市場レポート (2020-2030年):COVID 19による影響と成長
出版日: 2020年09月09日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の抗喘息薬・COPD治療薬市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域・国別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 抗喘息薬・COPD治療薬市場の特徴

第3章 抗喘息薬・COPD治療薬の市場規模と成長

  • 世界の抗喘息薬・COPD治療薬市場実績 (金額ベース)
    • 市場の成長要因
    • 市場の抑制要因
  • 世界の抗喘息薬・COPD治療薬市場予測 (金額ベース)
    • 市場の成長要因
    • 市場の抑制要因

第4章 抗喘息薬・COPD治療薬市場のセグメンテーション

  • 世界の抗喘息薬・COPD治療薬市場、実績と予測 (金額ベース) :薬剤クラス別
    • 気管支拡張薬
    • 抗炎症薬
    • モノクローナル抗体
    • 併用薬
  • 世界の抗喘息薬・COPD治療薬市場、実績と予測 (金額ベース) :エンドユーザー別
    • 喘息患者
    • COPD患者
  • 世界の抗喘息薬・COPD治療薬市場、実績と予測 (金額ベース) :流通チャネル別
    • 病院薬局
    • 個人病院
    • ドラッグストア
    • 小売薬局
    • eコマース

第5章 抗喘息薬・COPD治療薬市場:地域別および国別分析

  • 世界の抗喘息薬・COPD治療薬市場、実績と予測 (金額ベース) :地域別
  • 世界の抗喘息薬・COPD治療薬市場、実績と予測 (金額ベース) :国別

第6章 アジア太平洋の抗喘息薬・COPD治療薬市場

  • 市場概要
  • 市場実績と予測 (金額ベース) :薬剤クラス別
  • 市場実績と予測 (金額ベース) :エンドユーザー別

第7章 中国の抗喘息薬・COPD治療薬市場

第8章 インドの抗喘息薬・COPD治療薬市場

第9章 日本の抗喘息薬・COPD治療薬市場

第10章 オーストラリアの抗喘息薬・COPD治療薬市場

第11章 インドネシアの抗喘息薬・COPD治療薬市場

第12章 韓国の抗喘息薬・COPD治療薬市場

第13章 西欧の抗喘息薬・COPD治療薬市場

第14章 英国の抗喘息薬・COPD治療薬市場

第15章 ドイツの抗喘息薬・COPD治療薬市場

第16章 フランスの抗喘息薬・COPD治療薬市場

第17章 東欧の抗喘息薬・COPD治療薬市場

第18章 ロシアの抗喘息薬・COPD治療薬市場

第19章 北米の抗喘息薬・COPD治療薬市場

第20章 米国の抗喘息薬・COPD治療薬市場

第21章 南米の抗喘息薬・COPD治療薬市場

第22章 ブラジルの抗喘息薬・COPD治療薬市場

第23章 中東の抗喘息薬・COPD治療薬市場

第24章 アフリカの抗喘息薬・COPD治療薬市場

第25章 抗喘息薬・COPD治療薬市場の競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Novartis AG
    • Merck & Co
    • GlaxoSmithKline
    • Boehringer Ingelheim Gmbh
    • AstraZeneca

第26章 抗喘息薬・COPD治療薬市場における主要な合併と買収

第27章 抗喘息薬・COPD治療薬の市場動向と戦略

第28章 製品パイプライン分析

第29章 抗喘息薬・COPD治療薬市場の将来展望と潜在力分析

第30章 付録

目次

Anti-Asthmatics And COPD Drugs Global Market Report 2020-30: Covid 19 Implications and Growth from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for anti-asthmatics and copd drugs due to COVID 19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the anti-asthmatics and copd drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Asthmatics And COPD Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Drug Class: Bronchodilators; Anti-inflammatory Drugs; Monoclonal Antibodies; Combination Drugs

2) By End User: Asthma Patients; COPD Patients

3) By Distribution Channel: Hospital Pharmacies; Private Clinics; Drug Stores; Retail Pharmacies; E-Commerce

Companies Mentioned: Novartis AG; Merck & Co; GlaxoSmithKline; Boehringer Ingelheim Gmbh; AstraZeneca

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Anti-Asthmatics And COPD Drugs Market Characteristics

3. Anti-Asthmatics And COPD Drugs Market Size And Growth

  • 3.1. Global Anti-Asthmatics And COPD Drugs Historic Market, 2015-2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Anti-Asthmatics And COPD Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Anti-Asthmatics And COPD Drugs Market Segmentation

  • 4.1. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Bronchodilators
    • Anti-inflammatory Drugs
    • Monoclonal Antibodies
    • Combination Drugs
  • 4.2. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Asthma Patients
    • COPD Patients
  • 4.3. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospital Pharmacies
    • Private Clinics
    • Drug Stores
    • Retail Pharmacies
    • E-Commerce

5. Anti-Asthmatics And COPD Drugs Market Regional And Country Analysis

  • 5.1. Global Anti-Asthmatics And COPD Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Anti-Asthmatics And COPD Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market

  • 6.1. Asia-Pacific Anti-Asthmatics And COPD Drugs Market Overview
  • 6.2. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Anti-Asthmatics And COPD Drugs Market

  • 7.1. China Anti-Asthmatics And COPD Drugs Market Overview
  • 7.2. China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Anti-Asthmatics And COPD Drugs Market

  • 8.1. India Anti-Asthmatics And COPD Drugs Market Overview
  • 8.2. India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Anti-Asthmatics And COPD Drugs Market

  • 9.1. Japan Anti-Asthmatics And COPD Drugs Market Overview
  • 9.2. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Anti-Asthmatics And COPD Drugs Market

  • 10.1. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Anti-Asthmatics And COPD Drugs Market

  • 11.1. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Anti-Asthmatics And COPD Drugs Market

  • 12.1. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Anti-Asthmatics And COPD Drugs Market

  • 13.1. Western Europe Anti-Asthmatics And COPD Drugs Market Overview
  • 13.2. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Anti-Asthmatics And COPD Drugs Market

  • 14.1. UK Anti-Asthmatics And COPD Drugs Market Overview
  • 14.2. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Anti-Asthmatics And COPD Drugs Market

  • 15.1. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Anti-Asthmatics And COPD Drugs Market

  • 16.4. France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Anti-Asthmatics And COPD Drugs Market

  • 17.1. Eastern Europe Anti-Asthmatics And COPD Drugs Market Overview
  • 17.2. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Anti-Asthmatics And COPD Drugs Market

  • 18.1. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Anti-Asthmatics And COPD Drugs Market

  • 19.1. North America Anti-Asthmatics And COPD Drugs Market Overview
  • 19.2. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Anti-Asthmatics And COPD Drugs Market

  • 20.1. USA Anti-Asthmatics And COPD Drugs Market Overview
  • 20.2. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Anti-Asthmatics And COPD Drugs Market

  • 21.1. South America Anti-Asthmatics And COPD Drugs Market Overview
  • 21.2. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Anti-Asthmatics And COPD Drugs Market

  • 22.1. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Anti-Asthmatics And COPD Drugs Market

  • 23.1. Middle East Anti-Asthmatics And COPD Drugs Market Overview
  • 23.2. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Anti-Asthmatics And COPD Drugs Market

  • 24.1. Africa Anti-Asthmatics And COPD Drugs Market Overview
  • 24.2. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Anti-Asthmatics And COPD Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Anti-Asthmatics And COPD Drugs Market Competitive Landscape
  • 25.2. Anti-Asthmatics And COPD Drugs Market Company Profiles
    • 25.2.1. Novartis AG
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Merck & Co
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. GlaxoSmithKline
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Boehringer Ingelheim Gmbh
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. AstraZeneca
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market

27. Anti-Asthmatics And COPD Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Anti-Asthmatics And COPD Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.